General form of registration statement for all companies including face-amount certificate companies

Condensed Consolidated Balance Sheets (Q1)

v3.20.2
Condensed Consolidated Balance Sheets (Q1) - USD ($)
$ in Thousands
Mar. 31, 2020
Dec. 31, 2019
Mar. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
Current Assets          
Cash and cash equivalents $ 1,842 $ 2,361   $ 3,946  
Restricted cash 25 173   0  
Accounts receivable, net 6,121 5,824   116  
Inventories, net 4,762 6,580   1,557  
Prepaid expenses and other current assets 3,064 2,641   269  
Total current assets 15,814 17,579   5,888  
Noncurrent Assets          
Property and equipment, net 349 417   71  
Right-of-use asset, operating lease 888 951   0  
Intangible assets, net 14,259 14,641 $ 0 0  
Goodwill 18,614 18,614   0  
Other assets 1,027 1,330   28  
Total Assets 50,951 53,532   5,987  
Current Liabilities          
Short term loan, net 17,023 16,061   0  
Line of credit, net 5,366 4,819   4,600  
Other liabilities 209 500   1,914  
Accounts payable 4,226 4,049   765  
Accrued liabilities 4,570 4,721   85  
Deferred revenue 330 311   65  
Operating lease liability, current portion 352 345   0  
Warrant derivative liability 841 2,220   0  
Total current liabilities 32,917 33,026   9,029  
Noncurrent Liabilities          
Notes payable, net 17,559 16,370   0  
Operating lease liability 566 641   0  
Total Noncurrent Liabilities 18,125 17,011   0  
Total Liabilities 51,042 50,037   9,029  
Stockholders' Deficit          
Common stock, $0.001 par value, 88,000,000 shares authorized, 48,939,708 & 47,977,390 shares issued and outstanding at March 31, 2020 and December 31, 2019 49 48   12  
Additional paid-in capital 200,051 194,150   13,642  
Accumulated deficit (210,757) (201,269)   (16,698)  
Total Stockholders' Deficit (10,657) (7,071) $ (5,462) (3,042) $ (2,116)
Total Liabilities, Redeemable Preferred Stock and Stockholders' Deficit 50,951 53,532   5,987  
Series E Preferred Stock [Member]          
Redeemable Series E Convertible Preferred Stock          
Redeemable Series E preferred stock, $0.001 par value, 2,900,000 shares authorized, 1,387,378 shares issued and outstanding at March 31, 2020 and December 31, 2019 $ 10,566 $ 10,566   $ 0